Stay updated with breaking news from Christopher Ahern. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
New startup hC Bioscience is developing therapies based on transfer RNA, molecules that can be leveraged to address disease-causing proteins. The biotech joins several companies that are developing tRNA therapies in this emerging class of genetic medicines.
Combining a strong syndicate of investors, seasoned management, and exemplary scientific advisorshC Bioscience is developing a new class of therapy for...
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Press release content from PR Newswire. The AP news staff was not involved in its creation.
NEW YORK, Oct. 28, 2021 /PRNewswire/ -- The Muscular Dystrophy Association (MDA) announced today the awarding of 18 new MDA grants totaling over $1.6 million toward neuromuscular disease research. The